Relation logo — Discovering the relationships at the heart of biology
to cur...

Relation

Discovering the relationships at the heart of biology to cure disease.

Founded 2019 United Kingdom London, United Kingdom 130 employees Unknown Total: $139.00M Biotechnology, Pharmaceutical

General Information

Company Name Relation
Founded Year 2019
Location United Kingdom London, United Kingdom +1
Employees 130
Industries Biotechnology, Pharmaceutical
Funding Stage Unknown
Social

Get notified when Relation moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

AI Insight

Bounce Watch AI
2 months ago

Relation is exhibiting strong strategic momentum, underscored by high-level government engagement and the prestigious recognition of its CTO. The company is actively signaling intent for a new funding round to fuel continued growth and solidify its leadership in the UK life sciences sector, building on a validated partnership with its strategic investor, Novartis.

Signal Types
Funding Hiring Recognition Strategic Partnerships Corporate Development
Strategic Labels
Fundraising Readiness Strategic Validation Biotech Scaling
Next Move: Fundraising
·
Impact: 9/10
·
Ideal For: Growth Equity & Strategic Biotech VCs — Late Stage

About Relation

Relation is an innovative player in the Biotechnology and Pharmaceutical sectors, based in the United Kingdom. Founded in 2019, this company is on the cutting edge of biotech, combining high-resolution biological insights with advanced machine learning techniques to pioneer new therapeutic solutions for complex diseases.

The company lives by its slogan: "Discovering the relationships at the heart of biology to cure disease." By integrating multi-omics data, single-cell analysis, and functional assays, Relation has developed a proprietary "Lab-in-the-Loop" technology, which allows them to efficiently identify druggable targets and accelerate the development of transformational medicines.

In a noteworthy milestone, Relation raised a $55.00M Late VC investment on 01 December 2025, led by the pharmaceutical giant Novartis. This funding signifies strong investor confidence in their groundbreaking approach to biotech and pharmaceuticals, boosting their potential to make significant advancements in disease understanding and therapy development.

Taxonomy: transformational medicines, human biology, single-cell analysis, multi-omics, drug discovery, clinical insights, genomics, patient tissue analysis, functional assays, human genetics, therapeutic programs, functional genomics, drug target selection

Services & Products

Transformational Medicines Development
Disease Understanding
Target Selection
Drug Discovery
Interdisciplinary Collaboration

Target Customers

Biotech and Pharma Companies Medical Researchers Healthcare Professionals Patients

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Late Vc •••••• 1
Investor
01 Dec 2025
Growth Equity Vc •••••• 1 •••• •••• 01 Dec 2024
Late Vc •••••• - 01 Mar 2024
Seed •••••• 8
Investor Investor Investor Investor Investor Investor
•••• ••••
01 Jun 2022
Late Vc •••••• - 01 Aug 2021

Relation Alternatives & Competitors

View All Alternatives
Relation vs
Quiver Bioscience
Quiver Bioscience United States

Decoding Brain Disease to Reimagine Drug Development

Acquired
47 employees
Biotechnology
Relation vs
NewLimit
NewLimit United States

NewLimit is a biotechnology company working to extend human healthspan by developing epigenetic repr...

Series C
55 employees
Biotechnology, Health Care
Relation vs

Deeper insights, better treatments - a single cell at a time

Corporate Round
51 employees
Biotechnology, Health and Wellness

FAQ About Relation

Discovering the relationships at the heart of biology to cure disease.
Relation was founded in 2019.
Relation is headquartered in London, United Kingdom.
Relation operates in the following industries: Biotechnology, Pharmaceutical.
Relation has approximately 130 employees.
Relation has completed 5 funding rounds, raising a total of $139.00M. The latest funding stage is Unknown.
Relation offers: Transformational Medicines Development, Disease Understanding, Target Selection, Drug Discovery, Interdisciplinary Collaboration.
Top alternatives and competitors to Relation include Quiver Bioscience, NewLimit, ThinkCyte, bitBiome, Inc., Etiome. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Relation and Quiver Bioscience are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Relation and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy